VanEck Pharmaceutical ETFVanEck Pharmaceutical ETFVanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF

No trades
See on Supercharts

VanEck Pharmaceutical ETF holdings


As of June 5, 2025
Symbol
Weight %
Shares
Shares Chg %
1M
Market value
Market value Chg %
1M
L
LLYEli Lilly and Company
11.44%
‪‪82.07 K‬‬
−14.80%
‪‪62.84 M‬‬USD
−20.58%
J
JNJJohnson & Johnson
6.41%
‪‪229.26 K‬‬
−14.80%
‪‪35.23 M‬‬USD
−15.54%
A
ABBVAbbVie, Inc.
6.18%
‪‪181.22 K‬‬
−14.80%
‪‪33.97 M‬‬USD
−18.53%
N
NVSNovartis AG Sponsored ADR
5.65%
‪‪263.65 K‬‬
−14.80%
‪‪31.06 M‬‬USD
−11.25%
C
CORCencora, Inc.
5.33%
‪‪101.49 K‬‬
−14.79%
‪‪29.27 M‬‬USD
−15.83%
M
MCKMcKesson Corporation
5.21%
‪‪40.23 K‬‬
−14.82%
‪‪28.63 M‬‬USD
−14.26%
H
HLNHaleon PLC Sponsored ADR
5.12%
‪‪2.53 M‬‬
−14.80%
‪‪28.13 M‬‬USD
−10.87%
N
NVONovo Nordisk A/S Sponsored ADR Class B
5.06%
‪‪382.96 K‬‬
−14.80%
‪‪27.82 M‬‬USD
−10.45%
A
AZNAstraZeneca PLC Sponsored ADR
4.99%
‪‪379.02 K‬‬
−14.80%
‪‪27.42 M‬‬USD
−14.49%
G
GSKGSK plc Sponsored ADR
4.96%
‪‪663.01 K‬‬
−14.80%
‪‪27.28 M‬‬USD
−9.76%
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.